Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adherence to exercise regimens is defined as the extent to which a person's behavior corresponds with the agreed recommendations from a healthcare provider regarding physical activity (World Health Organization, 2003). It is a behavioral outcome rather than a molecular target such as a receptor, enzyme, or transporter; therefore, it cannot be engaged by traditional pharmacological agents. Consistent adherence is critical for the primary and secondary prevention of chronic metabolic and cardiovascular diseases, including type 2 diabetes and hypertension (NIH, PMC4129661). Factors influencing adherence are multifactorial, encompassing psychological motivation, socioeconomic status, and physical capability (PubMed, 22441968). In clinical research, improving adherence is a major goal of behavioral interventions and digital health technologies rather than drug development.
Not applicable. Adherence to exercise regimens is a behavioral construct and clinical endpoint, not a biological molecule or receptor that can be targeted by pharmacological ligands.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adherence to exercise regimens.